Dr. Robert Stowe

Clinical Professor, UBC Department of Psychiatry

Member, UBC Clinical Research Board and Djavad Mowafaghian Centre for Brain Health (DMCBH)

Co-Chair, Neuropsychiatric Genetics Special Interest Group, American Neuropsychiatric Association

Email: robert.stowe@ubc.ca

Publications

View an extended list of peer-reviewed publications on ORCID

  • T74. HIGH YIELD OF DEEP PHENOTYPING AND LONG READ WHOLE GENOME SEQUENCING IN TREATMENT-RESISTANT PSYCHOSISEuropean Neuropsychopharmacology2024-10 | journal-article
  • SETD1A variant-associated psychosis: A systematic review of the clinical literature and description of two new casesProgress in Neuro-Psychopharmacology and Biological Psychiatry2024 | journal-article
  • The curious absence of psychosis in GRIN1-related neurodevelopmental disorderEuropean Archives of Psychiatry and Clinical Neuroscience2024 | journal-article
  • Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophreniaCPT: Pharmacometrics and Systems Pharmacology2024 | journal-article
  • A 1p31.3 deletion encompassing the nuclear factor 1A gene presenting as possible temporal lobe epilepsy in association with schizoaffective disorderNeurocase2022-10-09 | journal-article
  • ASSESSING THE UTILITY OF PHARMACOGENETIC TESTING IN A COHORT WITH TREATMENT-RESISTANT SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDEREuropean Neuropsychopharmacology2022-10 | journal-article
  • Subjective cognitive functioning, depressive symptoms, and objective cognitive functioning in people with treatment-resistant psychosisCognitive Neuropsychiatry2022-08-05 | journal-article
  • Progressive neurocognitive decline in schizophrenia: A diagnostic dilemma for cliniciansSchizophrenia Research2022-03 | journal-article
  • Whole-genome sequencing analysis of clozapine-induced myocarditisPharmacogenomics Journal2022 | journal-article
  • TU71. SIGNIFICANT INCIDENCE OF RARE CHROMOSOMAL AND GENOMIC SEQUENCE VARIANTS IN HIGHLY TREATMENT-RESISTANT SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDEREuropean Neuropsychopharmacology2021-10 | journal-article
  • Review and Consensus on Pharmacogenomic Testing in PsychiatryPharmacopsychiatry2021 | journal-article
  • First Whole Transcriptome RNAseq on CHD8 Haploinsufficient Patient and Meta-Analyses Across Cellular Models Uncovers Likely Key Pathophysiological Target GenesCureus2020-11-19 | journal-article
  • Treatment-resistant psychotic symptoms and early-onset dementia: A case report of the 3q29 deletion syndromeSchizophrenia Research2020-09 | journal-article
  • Clinical and biochemical footprints of inherited metabolic diseases. III. Psychiatric presentations.Molecular genetics and metabolism2020-02 | journal-article